INSIDERFilingvia Quantisnow
Adial Pharmaceuticals Inc logo

Adial Pharmaceuticals (ADIL) director Young bought 36,378 Pre-funded Warrant for $100K at $2.75

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Wendy B. Young (director at Adial Pharmaceuticals Inc, ADIL) reported that they bought 36,378 Pre-funded Warrant for $100K at $2.75 on Jun 12, 2026.

Reporting person
Young Wendy B.

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 12, 2026Open-market purchase (P)Pre-funded WarrantOn 36,378 Common Stock1, 2+36,378$2.75$100K36,378 direct

Holdings before and after

  • Pre-funded Warrant: 0 to 36,378 direct

Footnotes from the filing

  1. 1. Pursuant to the terms of that certain Pre-Funded Warrant to Purchase Common Stock, dated June 12, 2026, issued by the Issuer to the Reporting Person pursuant to a securities purchase agreement entered into by and among the Issuer, the Reporting Person and certain other parties on June 11, 2026.
  2. 2. The pre-funded warrants to purchase shares of the Issuer's common stock (the Pre-Funded Warrants ) have no expiration date and are exercisable at any time after receiving approval of the Issuer's stockholders. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Young report in this ADIL Form 4?

Wendy B. Young (director at Adial Pharmaceuticals Inc, ADIL) reported that they bought 36,378 Pre-funded Warrant for $100K at $2.75 on Jun 12, 2026.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for ADIL

Across the 15 sessions after earlier ADIL headlines, the stock closed higher 5 times and lower 10 times, with a median move of 4.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Earlier insider filings at ADIL

Quantisnow market dataNASDAQ
Adial Pharmaceuticals Inc logo
ADIL
Adial Pharmaceuticals Inc
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2018
Get push alerts for ADIL

Follow ADIL and get a push notification the moment its next story breaks.

Full ADIL profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADIL (Adial Pharmaceuticals Inc) and more on Quantisnow.